Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Payables (2017 - 2025)

Historic Payables for Neuronetics (STIM) over the last 9 years, with Q3 2025 value amounting to $11.6 million.

  • Neuronetics' Payables rose 25122.91% to $11.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 million, marking a year-over-year increase of 25122.91%. This contributed to the annual value of $11.1 million for FY2024, which is 13310.19% up from last year.
  • According to the latest figures from Q3 2025, Neuronetics' Payables is $11.6 million, which was up 25122.91% from $9.7 million recorded in Q2 2025.
  • In the past 5 years, Neuronetics' Payables registered a high of $11.6 million during Q3 2025, and its lowest value of $2.4 million during Q2 2022.
  • In the last 5 years, Neuronetics' Payables had a median value of $3.3 million in 2021 and averaged $4.8 million.
  • Its Payables has fluctuated over the past 5 years, first plummeted by 4340.54% in 2022, then skyrocketed by 25122.91% in 2025.
  • Quarter analysis of 5 years shows Neuronetics' Payables stood at $4.3 million in 2021, then plummeted by 43.41% to $2.4 million in 2022, then soared by 95.31% to $4.8 million in 2023, then skyrocketed by 133.1% to $11.1 million in 2024, then grew by 4.48% to $11.6 million in 2025.
  • Its last three reported values are $11.6 million in Q3 2025, $9.7 million for Q2 2025, and $8.5 million during Q1 2025.